Background-Whether disclosing genetic risk for coronary heart disease (CHD) to individuals influences information seeking and information sharing is not known. We hypothesized that disclosing genetic risk for CHD to individuals influences information seeking and sharing. Methods and Results-The MI-GENES study (Myocardial Infarction Genes) randomized participants (n=203) 
nabling and empowering patients to participate in their healthcare is critical to the implementation of precision (or personalized) medicine and improving healthcare outcomes. 1, 2 Increased patient engagement and participation in their care promotes truly personalized healthcare 3, 4 and associates with subsequent healthier behaviors, better clinical outcomes, and lower healthcare costs. 5 Such patient participation involves an electronic healthcare journey 2 that includes where participants go to seek information about their health and whether they access a limited view of the electronic health record in the form of a personal health record (PHR) via the patient portal. The patient journey also involves sharing of health information in the patient's biological and social networks.
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Health information seeking and sharing facilitate informed decision making through augmenting the patient's knowledge of disease processes, preventive behaviors, and therapeutic options and associate with the practice of healthy behaviors. 6, 7 The internet enables patients to access health information 8 (from websites or the PHR) and share information about their disease risk with others through email or on social media platforms. Gaining further insight into the patient's information seeking and sharing behaviors after disclosure of disease risk for health promotion may help ensure available, accessible, and high quality health information to enable patients (ie, e-patients 2 ) to engage with their physicians. Seeking and sharing of genetic information in particular have implications for the health not only of the index patient but also of a patient's family, household members, and friends. 9 Individuals often seek and share their genetic risk information in the midst of their kinship, given that the risk may also be shared by their family members. Not only does this increase awareness in families but also perception of genetic risk information because a shared threat might catalyze joint interventions among family. 10 This differentiates the impact of disclosing genetic risk information from disclosing nongenetic risk information alone. Nevertheless, for chronic complex diseases (eg, coronary heart disease [CHD]) with Information Seeking/Sharing After GRS Disclosure common susceptibility gene variants, risk can be modified by shared environment and behaviors in individuals beyond biological kinship. As a result, sharing risk information with nonbiological household members and friends could also help to propagate health information in the patient's social network. 10 CHD remains the leading cause of morbidity and mortality worldwide and is consequently a public and global health priority. 11 Several prospective cohort or case-control studies and a meta-analysis have shown that a multilocus genetic risk score (GRS) for CHD can help restratify patients to higher or lower risk for developing CHD. [12] [13] [14] [15] [16] [17] [18] [19] A GRS was predictive of CHD events and clinical benefit from statins ( Figure I in the Data Supplement) 19 and disclosure of such a GRS to individuals influencesd statin initiation. 20 One study assessed the impact of direct-to-consumer CHD susceptibility genotypes on information seeking and sharing. 21 In that study, participants appreciated the nondeterministic contributions of their genetics and behavior to CHD risk. Most individuals searched online for information about the effect of health habits and family history on CHD risk and also discussed their CHD genotype risk information with their spouses, family members, and healthcare providers. Although this study provided a report on direct-toconsumer disclosure of genotypic information, the influence of disclosing a multilocus GRS for CHD on information seeking and sharing behavior has yet to be studied.
In a post hoc analysis of the MI-GENES study (Myocardial Infarction Genes), we hypothesized that disclosure of a GRS for CHD would increase information seeking and sharing with others in patients' biological and social networks. We also hypothesized that this would differ between individuals with high GRS and those with low GRS.
Materials and Methods

MI-GENES Study
The MI-GENES study design has recently been reported 20 ( Figure 1 ). Informed consent was obtained from all subjects. The study was approved by the Mayo Clinic Internal Review Board. Trial participants (n=203) were white residents of Olmsted County, Minnesota, aged 45 to 65 years, not on statins, at intermediate risk for CHD (5%-20%; 10-year Framingham risk score; Table 1 ). Computer-generated randomization assigned patients (1:1) to the conventional risk score (CRS) group or the GRS group by stratifying for age, sex, and family history for CHD. 20 The study was not blinded. Baseline lipid levels were measured, and low-density lipoprotein cholesterol levels were estimated. Three months later, risk was disclosed by a genetic counselor in a standardized session. Participants randomized to the CRS group received their CRS, which was discussed with the genetic counselor along with a brief review of family history. Participants randomized to the GRS group received their GRS and a combined GRS and CRS (GRS multiplied by CRS). The interpretation of the score was discussed by the genetic counselor along with a brief review of family history and discussion of the probabilistic nature of the GRS. In addition, the genetic counselor recommended dietary and lifestyle modifications that aim to reduce the participants' CHD risk in both the CRS and GRS groups. This was followed by shared decision making (SDM) with a physician to determine the need for statin therapy. 22 Study physicians used a web-based clinical decision support tool-a version of the Mayo Clinic Statin Choice Decision Aid (http://migenesstudy.mayoclinic.org, password: migenes) modified for research purposes to include the GRS used in MI-GENES. Patients were shown a pictograph demonstrating their percentage CRS and then the genotype-informed risk after multiplication of the CRS by the GRS if randomized to receive their GRS. The pictograph depicted 100 people like the participant and indicated how many could be expected to experience an adverse CHD event over the next 10 years. We also assessed study participants' perception of the SDM process and satisfaction with the physician encounter and used an established observing patient involvement questionnaire while viewing the videotaped SDM patient-physician office visits and demonstrated that there was no difference in the perception or quality of SDM between the 2 groups. 22 At 3 and 6 months post-disclosure, low-density lipoprotein cholesterol levels were determined and results were placed in the electronic health record. The primary end point of the trial was change in low-density lipoprotein cholesterol at 6 months post-disclosure, and secondary end points included statin initiation and changes in fat intake or physical activity. 20 Psychosocial parameters were also addressed, including information seeking and sharing.
Information Seeking and Sharing Surveys
The majority of survey questions were adapted from Health Information National Trends (HINTS) Surveys (http://hints.cancer.gov) and other established surveys 21, [23] [24] [25] [26] [27] (Table I in the Data Supplement).
The Internet Use survey was administered at 3 and 6 months postdisclosure ( The Information Seeking survey was completed at 3 and 6 months post-disclosure and used a Likert scale of 1 for No, 2 for Yes, and 3 for Not applicable (Tables I and III in the Data Supplement). Given the low frequency of responses for No and Not applicable, these were considered unfavorable and given a score of 1, whereas Yes was considered favorable and given a score of 2. Questions about the effects of personal habits and genetics on CHD risk were adapted from Kaphingst et al 21 The Information Sharing survey was administered at 3 and 6 months post-disclosure (Tables I and IV in the Data Supplement). The questions "Have you discussed your CHD risk with others?" and "Who did you talk to about your results: friends, family members, coworkers, other?" were adapted from Kaphingst et al 21 ( Table 3 ). The first question used a Likert scale of 1 for Not at all, 2 for Very few, 3 for Some, 4 for A fair number, and 5 for Frequently. For the second survey question, 1 point was given for each of 4 spheres of influence in the participant's information sharing radius ( Figure III in the Data Supplement). For the remaining questions in the survey, a Likert scale of 1 for No, 2 for Yes, and 3 for Not applicable was used. Given the low frequency of responses for No, Not Applicable, Not at all, and Very few, these were considered unfavorable whereas Some, A fair number, Frequently, and Yes were considered favorable, with a score of 1 for unfavorable and 2 for favorable. The following question was added to expand on participants' responses regarding those with whom they discussed their CHD risk: "Did you share your CHD Information Seeking/Sharing After GRS Disclosure risk with your parents, siblings, spouse, children, extended family, or PCP)?." The question "Have you encouraged others to be screened for risk of having a heart attack?" was also added.
The Social Network survey was completed at baseline and 3 and 6 months post-disclosure (Tables I and V in the Data Supplement). The survey used a Likert scale of 1 for No, 2 for Yes, and 3 for Don't know. Given the low frequency of responses for No and Don't know, these were considered unfavorable and given a score of 1 whereas Yes was considered favorable and given a score of 2. The questions "Do you have friends or family members that you talk to about your health?" and "Do any community organization(s) provide you with information on health?" were adapted from HINTS 2005 (Table 3 ; also see Assessment of Social Media Responses in the Data Supplement).
Statistical Methods
Survey data were extracted from the Research Electronic Data Capture 28 software. Data analyses were conducted using JMP V9.0.2 (SAS Institute Inc., Cary, NC). Missing data were imputed using the mode for that survey question in the CRS or GRS group in which the missing data appeared. Survey results were compared in single visit survey responses and also between visits to investigate changes in survey responses over time. Because of low frequencies of unfavorable responses among participants, each Likert scale was converted to a binary scale with a score Figure 1 . Study design. A, Of ≈30 000 individuals available in the Mayo Clinic BioBank, ≈2000 met the screening criteria. A random 1000 were selected, with 966 successfully genotyped. After targeted recruitment of at least 110 individuals with high genetic risk score (GRS) and 110 with average/low GRS, 216 participants enrolled; subsequently, 9 withdrew. Thus, 207 were randomized to the conventional risk score (CRS) and GRS groups; 203 remained at follow-up. Information seeking (○) was assessed at baseline and at 3 and 6 months postdisclosure. Information sharing (∆) was assessed at 3 and 6 months post-disclosure. CHD indicates coronary heart disease. CHD indicates coronary heart disease; CRS, conventional risk score; and GRS, genetic risk score.
*Some college education, a college degree, or higher. Information Seeking/Sharing After GRS Disclosure of 1 for unfavorable and 2 for favorable responses as described in the preceding section. Scores were calculated for individual survey questions, with a higher number indicating a more favorable response. GRS was stratified as high (≥1.1; H-GRS) or low/average (<1.1; H-GRS) risk. We assessed whether information exchange differed by GRS versus CRS or by high versus low GRS disclosure. Logistic regression was used to estimate the effect of the randomized group on the binary score for each survey question. Ordered logistic regression was used to estimate the effect of the randomized group on the ordinal sharing radius ( Figure III in the Data Supplement). Data were adjusted for the following baseline socioeconomic demographics: age, sex, family history of CHD, and level of education (Table 1) . These demographic characteristics were also investigated as potential predictors using multivariate analyses 29, 30 for survey questions with responses significantly different between the GRS and CRS groups (see Multivariate Logistic Regression Assessing Potential Predictors in the Data Supplement; Table VI in the Data Supplement). Data were also adjusted for baseline CRS and GRS and were expressed as odds ratio (OR) with confidence interval (CI) or mean with SE. Statistical significance was accepted as P<0.05.
Post Hoc Power Analysis
A post hoc power analysis was performed for each survey question using an online application (located at http://clincalc.com/stats/ Power.aspx). The obtained sample sizes and responses for each group were used to determine the power for an α of 0.05, assuming that the observed effect size based on the responses in the CRS group and the GRS group in the study sample was equivalent to the unmeasured effect size of the corresponding greater population.
Results
Participants in the 2 study groups had similar sociodemographic characteristics (Table 1) ; all data were adjusted for these sociodemographic characteristics, using multivariate logistic regression. Notably, most (60%-70%) trial participants had some college education, a college degree, or higher. Baseline survey responses were also similar between the 2 groups (see Baseline Survey Parameters in the Data Supplement; Table VII in the Data Supplement). Overall, following risk disclosure GRS group participants were more likely than CRS group participants to seek health information online and in their PHR and were more likely to share their CHD risk information with others as described in the following sections.
Information Seeking: Internet Use Outside of the PHR
GRS participants trended toward being more likely than CRS participants to visit a website specifically to learn about CHD 
Information Seeking: PHR Access
At 3 months post-disclosure, there was no difference between CRS and GRS participants regarding using the patient portal to access CHD risk, having access to the Mayo Clinic Patient Portal, signing up for the patient portal, or using the internet to communicate with a doctor's office or keep track of personal health information (Table 2 ). However, this increased over time in the GRS group, such that at 6 months post-disclosure, GRS participants were more likely than CRS participants to use the patient portal to access their CHD risk (OR, 2.99 [1. .04]; P=0.01; Figure 2A ; Table 2 Figure 2B ; Figure 2C ; Figure III in 
Social Network
There was no significant difference in social network between the GRS and CRS participants at 3 months post-disclosure (Table 3) . GRS participants trended toward having more friends or family members with whom they discussed their health than CRS participants at 6 months post-disclosure (OR, 1.92 [CI, 0.92-4.11]; P=0.08). H-GRS individuals were more likely than CRS individuals to report having friends or family members with whom they discussed health at 6 months postdisclosure (OR, 3.24 [CI, 1.13-10.85]; P=0.03).
Post Hoc Power Analysis
The MI-GENES study was not specifically powered to assess information seeking and sharing. Consistent with this, a post A, Internet use and electronic health record (EHR)/personal health record (PHR) access at baseline and 3 and 6 months after risk disclosure with significant P values (*P<0.05) for the mean difference between values at 3 and 6 months post-disclosure; shared decision making for statin initiation and documentation of subsequently lowered low-density lipoprotein cholesterol (LDL-c) levels in the chart are completed by or at 3 months post-disclosure before observation of significant changes in information seeking and sharing survey responses between the conventional risk score (CRS) and GRS groups from 3 and 6 months postdisclosure. B, Information sharing at 3 months post-disclosure with significant P values (*P<0.05) for the mean difference between values at 3 and 6 months post-disclosure. C, Sharing radius (see Figure III in the Data Supplement) at 3 months post-disclosure, with distribution skewed toward a maximum score ∑=4 for GRS participants. D, The time course of statin use and lowering of LDL-C levels in CRS and GRS participants potentially mirrors significant changes in information seeking and sharing; LDL-C decreased from baseline significantly more in GRS participants because of higher statin use relative to CRS participants. CHD indicates coronary heart disease. Information Seeking/Sharing After GRS Disclosure hoc power analysis suggested that the study was overall underpowered (β<0.80 for each survey response) for this analysis. Regardless, several statistically significant differences were noted between the CRS and GRS group, revealing salient patterns of information seeking and sharing between the 2 groups. The effect size for each of several survey responses was described in the previous sections.
Discussion
Disclosure of CHD risk estimates that included a GRS led to increased information seeking and information sharing behaviors in the MI-GENES trial. Early on in the study, CRS participants trended toward being more likely to search for information about the effect of genetic factors on CHD risk, likely due to personal curiosity and being randomized to the group not receiving genetic risk information. Genetic risk information was not discussed with CRS participants. However, the impact of family history on CHD risk was briefly reviewed. All study participants were made aware at their first study visit that they would receive either a CRS or a GRS combined with their CRS at the second study visit. CRS participants were also informed that they would receive their genotype-informed risk at the end of the trial. This may have enticed interest in seeking information online about the impact of genetics on CHD risk in a somewhat comparable fashion to the participants who received their genotype-informed risk early on in the study. Over time, there was an increase among GRS participants in seeking information related to the effect of genetics on CHD risk while this behavior decreased in CRS participants.
Patients who received their GRS early on used the internet to seek health information and accessed their PHR through the patient portal more often than patients who received their CRS alone. This trend did not reach significance at 3 months post-disclosure but became significant at 6 months post-disclosure. This suggested that as the trial advanced, GRS participants were more interested in returning to retrieve their score. It is possible that GRS participants sought more information on genetics and CHD risk from websites online after observing a significantly lower low-density lipoprotein cholesterol level (than baseline, after significantly higher initiation of statin therapy than CRS participants at 3 months post-disclosure 20 ; Figure 2D ) placed in the electronic health record immediately after the visit at 3 months post-disclosure. This could contribute to increased information seeking from 3 to 6 months post-disclosure, supporting the important role of information seeking in the process of coping with health concerns. 31 Overall, individuals with high GRS exhibited even higher information seeking and sharing behaviors than L-GRS and CRS participants for various parameters, such as accessing health records to keep track of personal health information, sharing CHD risk with their PCP, and having friends and family with whom they discussed health, suggesting that a high GRS can assist with health promotion. However, L-GRS individuals were more likely to share their CHD risk with extended family members and encourage others to be screened for their CHD risk, likely reflecting their reassurance from the low risk result. These results suggest that in different ways, both high and low genetic risk can influence information seeking and sharing.
To facilitate informed decision making in precision medicine, we will need to ensure accurate sources of information online for patients, biological and social networks, physicians, and other healthcare workers. 1 Patients often present to their doctors with health information found online that is incorrect or of poor quality and with reports that useful health information is difficult to find electronically. 1, 23 Providing reliable information of good quality that is easy to find online will aid engagement of patients in precision medicine because they seek counsel from family and social networks to make decisions for their personalized care. 3 We provide a carefully selected list of internet websites identified by study participants or recommended by our group for patient and provider education along with further discussion of enhancing the GRS report for both patient and provider education (see Internet Websites and Enhancing GRS Reports in the Data Supplement).
GRS disclosure early on led to increased information sharing with others ( Figure III in the Data Supplement), particularly family members, friends, coworkers, and PCPs. Patients likely shared their CHD genetic risk information (above and beyond sharing of nongenetic risk information) with family members for social support and specifically because of anticipated shared risk as found in other studies. 32 Participants also shared their CHD risk information with others in their nonbiological social networks, most likely to obtain emotional support from friends and coworkers, and to aid continuity of care with their PCP. This would be consistent with studies suggesting that individuals rate their friends and family as their top source of emotional support and health professionals as their top source for technical health issues, such as diagnosis and treatment. 33 With patients sharing CHD risk information, there is potential for co-operative strategies to adopt healthy lifestyles or to make decisions for medication use to lower CHD risk, corresponding to a communal coping in social networks hypothesis (see Figure IV in the Data Supplement). 10 Our data, therefore, suggest that participants themselves can potentially have an impact on their community by sharing this health information. Network-based approaches have been shown to optimize population-level behavior changes 34 and should be explored in response to genetic risk disclosure. In addition, ongoing studies in our group are assessing participants' perceptions of experience, salience, beliefs, risk, knowledge, subjective norms, self-efficacy, locus of control, outcome expectations, attitudes, and social networks that fit into the Comprehensive Model of Information Seeking, expanded Planned Risk Information Seeking Model, Health Information Model, and other models of information behavior [35] [36] [37] [38] that can potentially be applied to social network medicine.
Information seeking and sharing behaviors in the MI-GENES study are more similar to behaviors noted in other genetic studies related to CHD and its risk factors than to cancer-related or nongenetic studies (see Information Seeking and Sharing Compared to Other Genetic and Nongenetic Studies in the Data Supplement). This is most likely because of perception of risk for various cancers as nonmodifiable Information Seeking/Sharing After GRS Disclosure whereas CHD risk is considered modifiable. Such behaviors include individuals who have received genetic risk information for CHD exhibiting high levels of seeking information online related to their test results or the effect of heritability or health habits on disease risk and sharing risk information with others including their PCPs, family, and friends. 21 Although the effect on information seeking and sharing reported here may not be exclusive to disclosure of a GRS for CHD, examining this relationship can be informative for CHD prevention and health promotion.
Interestingly, participants in the current study shared their risk information most with spouses, then with siblings or children, and least with parents. In contrast, in a study of heritable cancers, individuals shared their risk information most with their parents and least with their children. 39 This difference could be because of individuals who have received cancer genetic test results protecting their children from traumatic information 40 while individuals with CHD genetic risk information may share this readily with their spouses, siblings, and children not only because of shared risk but also because of the potential for communal coping and risk modification. Sharing risk information with nonbiological contacts has been reported in studies disclosing genetic risk for CHD and its risk factors (including this study) and also to disclosure of nongenetic medical information, 41 but this is not a frequent occurrence in cancer genetic risk studies. 39, 40 Although a meta-analysis inferred that disclosure of genetic risk estimates may not prompt behavioral changes (eg, diet, physical activity, and smoking), the majority of studies appraised disclosed only a single genotype primarily for cancers and risk factors for CHD (eg, obesity, hypertension, familial hypercholesterolemia, and type 2 diabetes mellitus). 42 No study disclosed a multilocus GRS for CHD, and information seeking and sharing were not assessed. One study revealed changes in medication use when comparing participants who received positive versus negative risk genotype results for Alzheimer disease. In another study, individuals who received genetic results displayed increased perception of medication efficacy, implying potential willingness to initiate medication had it not already been prescribed. 43 Several studies have suggested modest clinical use of a GRS for CHD. [12] [13] [14] [15] [16] [17] [18] [19] 44, 45 In our report of the primary outcomes of the MI-GENES randomized clinical trial, we presented evidence for significantly higher rates of medication use (ie, statin initiation) in those who received their probabilistic GRS for CHD relative to conventional risk estimates alone, with a similar trend in those with high versus low GRS. 20 Thus, disclosure of a GRS for CHD may modify preventive medication use, in addition to information behavior promoting health (see Potential Impact of Information Behavior on Decision-Making in the Data Supplement).
This analysis of the MI-GENES trial is the first study of the impact of electronic health record-based disclosure of a GRS for CHD on information seeking and sharing. Strengths of the study include standardized genetic counseling and SDM with a physician in a randomized controlled trial. The post hoc power analyses indicated that the study was underpowered to detect differences in information seeking and sharing between the CRS and GRS groups, but the study revealed various statistically significant differences between the 2 groups, supporting the main theses of our results. Further studies focusing on information seeking and sharing should be adequately powered a priori to uncover additional trends and confirm data from the current study. Individuals may have been disappointed after randomization to the CRS group, which could influence their self-reported survey responses. The MI-GENES trial design was completed before publication of the American College of Cardiology/American Heart Association 2013 recommendations for blood cholesterol management. 46 As a result, the Framingham risk score was used in the MI-GENES study, predating the atherosclerotic cardiovascular disease pooled cohort equations. Beyond office visits, the PHR, and educational handouts, our study did not assess the quality of information sought or shared online or in participants' social networks.
Study participants were overall well-educated individuals of self-reported European ancestry living in Olmsted County in Minnesota; 60% to 70% of study participants reported some college education, a college degree, or higher. The education level of participants in this study is similar to previous epidemiological reports for Olmsted County, 47 as well as the national average for the general population 48 and populations reported in several other studies on health information seeking (see Potential Impact of Sociodemographic Characteristics on Information Behavior in the Data Supplement). Education and other sociodemographic characteristics are just 1 part of numerous parameters that shape information seeking. After adjusting for these sociodemographic characteristics, GRS disclosure led to further increase in information seeking and sharing.
